Beam Therapeutics (BEAM) News Today $16.73 +0.72 (+4.47%) As of 03:33 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BEAM Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Cathie Wood’s ARK Investment buys 509.6K shares of Beam Therapeutics todayAugust 20 at 8:49 PM | msn.comJonesTrading Reduces the PT on Beam Therapeutics (BEAM), Keeps a Buy RatingAugust 20 at 2:38 AM | msn.comCathie Wood’s ARK Investment buys 395K shares of Beam Therapeutics todayAugust 19 at 5:34 AM | msn.comLiontrust Investment Partners LLP Reduces Stock Position in Beam Therapeutics Inc. (NASDAQ:BEAM)August 18, 2025 | marketbeat.comVestmark Advisory Solutions Inc. Has $3.02 Million Stock Holdings in Beam Therapeutics Inc. (NASDAQ:BEAM)August 18, 2025 | marketbeat.comBeam Therapeutics: A Slow-Developing StoryAugust 17, 2025 | seekingalpha.comBank of America Securities Keeps Their Buy Rating on Beam Therapeutics (BEAM)August 15, 2025 | theglobeandmail.comBeam Therapeutics (BEAM) Receives a Buy from Leerink PartnersAugust 14, 2025 | theglobeandmail.comBeam Therapeutics (BEAM) Gets a Buy from Clear StreetAugust 14, 2025 | theglobeandmail.comBeam Therapeutics' Sickle Cell Treatment Gets FDA's Generative Medicine Advanced Therapy DesignationAugust 14, 2025 | marketwatch.comBeam Therapeutics Stock Surges After FDA Grants RMAT DesignationAugust 14, 2025 | msn.comBeam Therapeutics Announces U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to BEAM-101 for the Treatment of Sickle Cell DiseaseAugust 14, 2025 | globenewswire.comFY2025 EPS Forecast for Beam Therapeutics Cut by AnalystAugust 9, 2025 | marketbeat.comLeerink Partnrs Has Optimistic Outlook of BEAM Q3 EarningsAugust 9, 2025 | marketbeat.comWilliam Blair Issues Optimistic Forecast for BEAM EarningsAugust 9, 2025 | marketbeat.comWedbush Decreases Earnings Estimates for Beam TherapeuticsAugust 8, 2025 | marketbeat.comBeam Therapeutics (NASDAQ:BEAM) Price Target Lowered to $21.00 at BarclaysAugust 7, 2025 | marketbeat.comBeam Therapeutics Inc. (NASDAQ:BEAM) Given Average Rating of "Buy" by BrokeragesAugust 7, 2025 | marketbeat.comBeam Therapeutics (NASDAQ:BEAM) Releases Earnings Results, Beats Expectations By $0.04 EPSAugust 6, 2025 | marketbeat.comIQ EQ FUND MANAGEMENT IRELAND Ltd Boosts Stock Position in Beam Therapeutics Inc. (NASDAQ:BEAM)August 6, 2025 | marketbeat.comBeam Therapeutics Inc. (NASDAQ:BEAM) Shares Sold by Raiffeisen Bank International AGAugust 6, 2025 | marketbeat.comBeam Therapeutics Reports Second Quarter 2025 Financial Results and Provides Update on BEAM-302 Development Progress in Alpha-1 Antitrypsin Deficiency (AATD)August 5, 2025 | globenewswire.comBIT Capital GmbH Has $308,000 Stake in Beam Therapeutics Inc. (NASDAQ:BEAM)August 4, 2025 | marketbeat.comTD Asset Management Inc Grows Stock Position in Beam Therapeutics Inc. (NASDAQ:BEAM)August 3, 2025 | marketbeat.comUniversal Beteiligungs und Servicegesellschaft mbH Invests $717,000 in Beam Therapeutics Inc. (NASDAQ:BEAM)August 3, 2025 | marketbeat.comBeam Therapeutics Inc. (NASDAQ:BEAM) Insider Fmr Llc Sells 48,374 SharesAugust 2, 2025 | marketbeat.comFmr Llc Sells 48,374 Shares of Beam Therapeutics Inc. (NASDAQ:BEAM) StockAugust 2, 2025 | insidertrades.comBeam Therapeutics (BEAM) to Release Quarterly Earnings on TuesdayJuly 29, 2025 | marketbeat.comNeutron beam platform unites simulation and biology for advanced therapy researchJuly 27, 2025 | msn.comARK Investment Management LLC Acquires 1,412,060 Shares of Beam Therapeutics Inc. (NASDAQ:BEAM)July 27, 2025 | marketbeat.comNikko Asset Management Americas Inc. Boosts Stock Holdings in Beam Therapeutics Inc. (NASDAQ:BEAM)July 27, 2025 | marketbeat.comBank of New York Mellon Corp Boosts Stock Holdings in Beam Therapeutics Inc. (NASDAQ:BEAM)July 24, 2025 | marketbeat.comResearch Analysts Offer Predictions for BEAM FY2025 EarningsJuly 23, 2025 | marketbeat.comBeam Therapeutics (NASDAQ:BEAM) Stock Rating Upgraded by Cantor FitzgeraldJuly 22, 2025 | marketbeat.comBeam Therapeutics (NASDAQ:BEAM) Trading Up 7.6% - Still a Buy?July 21, 2025 | marketbeat.comWhat is Leerink Partnrs' Forecast for BEAM FY2026 Earnings?July 21, 2025 | marketbeat.comRadiotherapy of cancer: Researchers enable better cancer treatment using existing medical equipmentJuly 18, 2025 | msn.comBeam Therapeutics (BEAM) Announces Acquisition of an Early-Stage Life Sciences CompanyJuly 16, 2025 | msn.comBeam Therapeutics (NASDAQ:BEAM) Trading Down 5.6% - Here's What HappenedJuly 15, 2025 | marketbeat.comPeregrine Investment Management Inc. Has $4.38 Million Stake in Beam Therapeutics Inc. (NASDAQ:BEAM)July 13, 2025 | marketbeat.comBeam Therapeutics Inc. (NASDAQ:BEAM) Receives Consensus Recommendation of "Buy" from AnalystsJuly 13, 2025 | marketbeat.comFocused Beam Engraving Gift and RC Hobby Shop now selling RC model vehiclesJuly 12, 2025 | msn.comConcurrent Investment Advisors LLC Takes Position in Beam Therapeutics Inc. (NASDAQ:BEAM)July 11, 2025 | marketbeat.comBeam Therapeutics (NASDAQ:BEAM) Shares Gap Up - Here's WhyJuly 9, 2025 | marketbeat.comBeam Therapeutics Inc. Research & Ratings - Barron'sJuly 9, 2025 | barrons.comBeam Therapeutics Inc. Advanced Charts | BEAM | Barron'sJuly 9, 2025 | barrons.comD.A. Davidson & CO. Has $1.38 Million Stock Holdings in Beam Therapeutics Inc. (NASDAQ:BEAM)July 9, 2025 | marketbeat.comH.C. Wainwright Reiterates a Buy Rating on Beam Therapeutics (BEAM) With an $80 PTJuly 6, 2025 | msn.comInsider Selling: Beam Therapeutics Inc. (NASDAQ:BEAM) Insider Sells 876 Shares of StockJuly 4, 2025 | insidertrades.comBeam Therapeutics’ BEAM-101 Shows Promising Results in Sickle Cell Disease TrialJuly 3, 2025 | msn.com Get Beam Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BEAM and its competitors with MarketBeat's FREE daily newsletter. Email Address BEAM Media Mentions By Week BEAM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BEAM News Sentiment▼0.620.54▲Average Medical News Sentiment BEAM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BEAM Articles This Week▼67▲BEAM Articles Average Week Get Beam Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BEAM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CRSP News DNLI News EDIT News NTLA News TWST News VCYT News LEGN News RVMD News RYTM News RNA News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BEAM) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersSilver’s Still Under $35… For Now.Silver is trading around $33—but insiders are betting on a $70 breakout by year’s end. With supply shrinkin...GoldenCrest Metals | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!The “top secret” DeFi play Our #1 Coin Report reveals which protocol is building this institutional bridge...Crypto 101 Media | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beam Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Beam Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access